Randomised clinical trial: alosetron improves quality of life and reduces restriction of daily activities in women with severe diarrhoea-predominant IBS

Quality of Life in Patients With Irritable Bowel Syndrome

(2011) Hubert Mönnikes   JOURNAL OF CLINICAL GASTROENTEROLOGY

Rifaximin Therapy for Patients with Irritable Bowel Syndrome without Constipation

(2011) Mark Pimentel et al.   NEW ENGLAND JOURNAL OF MEDICINE

Ischemic Colitis and Complications of Constipation Associated With the Use of Alosetron Under a Risk Management Plan: Clinical Characteristics, Outcomes and Incidences

(2010) Lin Chang et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Evolution of Clinical Trials for Irritable Bowel Syndrome: Issues in End Points and Study Design

(2010) Ann Marie Trentacosti et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Efficacy of 5-HT3 Antagonists and 5-HT4 Agonists in Irritable Bowel Syndrome: Systematic Review and Meta-Analysis

(2009) Alexander C Ford et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

International Survey of Patients With IBS

(2009) Douglas A. Drossman et al.   JOURNAL OF CLINICAL GASTROENTEROLOGY

Self-Administered Cognitive Behavior Therapy for Moderate to Severe Irritable Bowel Syndrome: Clinical Efficacy, Tolerability, Feasibility

(2008) J LACKNER et al.   Clinical Gastroenterology and Hepatology

Effects of 5-Hydroxytryptamine (Serotonin) Type 3 Antagonists on Symptom Relief and Constipation in Nonconstipated Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

(2008) Viola Andresen et al.   Clinical Gastroenterology and Hepatology

Efficacy and tolerability of alosetron for the treatment of irritable bowel syndrome in women and men: A meta-analysis of eight randomized, placebo-controlled, 12-week trials

(2008) Roja Rahimi et al.   CLINICAL THERAPEUTICS